BackMeihua International Medical Technologies Co Overview

Meihua International Medical Technologies Co Common Stock

Track Meihua International Medical Technologies Co's common stock ($16K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$15951.00
↑ 22.27% YoYΔ $2905.00 vs prior year quarter

Peer trimmed avg / median

Loading

Meihua International Medical Technologies Co Common Stock History

Loading

Meihua International Medical Technologies Co vs. peers: Common Stock Comparison

Loading

Meihua International Medical Technologies Co Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Meihua International Medical Technologies Co (MHUA) FAQ

Meihua International Medical Technologies Co posts a common stock of $16K as of June 2025. That compares with $13K in the prior-year period — up 22.3% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Meihua International Medical Technologies Co's common stock was $13K. The latest reading is $16K — a 22.3% year-over-year increase (period ending June 2025). Use the history and growth charts on this page for a longer lookback.

Common Stock is one piece of Meihua International Medical Technologies Co's financial statement story. At $16K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for MHUA's common stock usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Meihua International Medical Technologies Co's other metric pages and overview cover the third.